Utility of Mdr1-Gene Deficient Mice in Assessing the Impact of P-glycoprotein on Pharmacokinetics and Pharmacodynamics in Drug Discovery and Development

By  

Current Drug Metabolism, Vol. 4, Iss. 4, 2003-08 ,pp. : 272-291

Bentham Science Publishers

Access to resources Recommend Favorite

Characterisation of cerivastatin as a P-glycoprotein substrate: studies in P-glycoprotein-expressing cell monolayers and mdr1a/b knock-out mice

By Kivistö Kari   Zukunft Jörg   Hofmann Ute   Niemi Mikko   Rekersbrink Sabine   Schneider Swetlana   Luippold Gerd   Schwab Matthias   Eichelbaum Michel   Fromm Martin  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 370, Iss. 2, 2004-08 ,pp. : 124-130

Springer Publishing Company

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells

By Storch Caroline   Klimm Hans-Dieter   Heinrich Tilman   Haefeli Walter   Weiss Johanna  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 376, Iss. 1-2, 2007-10 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

(Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) The Role of MDR1 Genetic Polymorphisms in Interindividual Variability in P-glycoprotein Expression and Function

By  

Current Drug Metabolism, Vol. 5, Iss. 1, 2004-02 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite